FIGURE

Figure 4

ID

ZDB-FIG-240415-80

Publication

Bezerra et al., 2024 - 3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 Breast Cancer Cell Line

Other Figures

All Figure Page

Back to All Figure Page

Figure 4

Comparison of cell viability between 3-NAntC and chemotherapy (doxorubicin and cisplatin). Cellular viability assays were performed on MDA-MB-231 (a–c) and HDFa (d–f) cell lines using the MTT method. Cells were treated with 3-NAntC, cisplatin, or doxorubicin for 24, 48, and 72 h at concentrations ranging from 0.2 to 2.0 µg/mL. Data are presented as mean ± SEM of at least three independent assays in triplicate. Significant differences between the control (0 µg/mL) and treated cells are designated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001, according to two-way ANOVA and a Bonferroni post hoc test.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Molecules